Literature DB >> 8417944

Prolonged independent lung respiratory treatment after single lung transplantation in pulmonary emphysema.

V Gavazzeni1, G Iapichino, D Mascheroni, M Langer, G Bordone, P Zannini, D Radrizzani, G Damia.   

Abstract

Single lung transplantation (SLT) is now successfully used in patients with severe emphysema. Mechanical imbalance between the native emphysematous and the healthy transplanted lung can be easily managed, unless severe graft failure occurs, leading to acute respiratory failure. Emergency retransplantation has been used in this setting, since the conventional approach to adult respiratory distress syndrome (ARDS) (mechanical ventilation and positive end-expiratory pressure [PEEP]) fails, due to the mechanical discrepancy between the two lungs. We describe two cases of severe graft failure following SLT in emphysema patients that were successfully treated with prolonged independent respiratory treatment. Mechanical ventilation and PEEP were applied to the failing transplanted lung while the native emphysematous lung was maintained on spontaneous breathing to avoid hyperexpansion and barotrauma. The independent lung respiratory treatment lasted 35 and 25 days, respectively: to our knowledge, these are among the longest-lasting independent respiratory treatments reported. The management was simplified by the early use of a double-lumen tracheostomy cannula as an alternative to orotracheal double lumen tube.

Entities:  

Mesh:

Year:  1993        PMID: 8417944     DOI: 10.1378/chest.103.1.96

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  [Unilateral vs. bilateral lung transplantation in obstructive pulmonary disease].

Authors:  U Bartram; S Demertzis; M Heilmann; T Wahlers; H J Schäfers
Journal:  Med Klin (Munich)       Date:  1997-12

Review 2.  Clinical review: Independent lung ventilation in critical care.

Authors:  Devanand Anantham; Raghuram Jagadesan; Philip Eng Cher Tiew
Journal:  Crit Care       Date:  2005-10-10       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.